COMMUNIQUÉS West-GlobeNewswire

Crossject annonce des progrès majeurs dans la fabrication de son traitement d’urgence ZEPIZURE®, pour la prise en charge des crises d’épilepsie, à l’approche du dépôt d’une demande d’autorisation d’utilisation d’urgence aux États-Unis.

22/10/2024 - 07:30

Le lot de produits annoncé en juillet a permis de recueillir davantage de données de stabilité, qui au premier trimestre 2025 soutiendront directement la stabilité requise de six mois. Crossject prévoit de déposer une [...]

Tecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launches

22/10/2024 - 07:20

Tecan’s Capital Markets Day highlights strategic growth drivers, groundbreaking innovation and product launches Männedorf, Switzerland, October 22, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) is hosting a Capital [...]

BioVersys Joins EU-Funded RespiriNTM Programme to Accelerate Development of Its Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases

22/10/2024 - 07:00

BASEL, Switzerland, Oct. 22, 2024 (GLOBE NEWSWIRE) -- RespiriNTM Programme allows BioVersys’ NTM project to access up to €2 million of non-dilutive funding BioVersys taps into key expertise of the established RespiriNTM [...]

BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

22/10/2024 - 06:30

Global 600 patient study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. Rhu-pGSN is an immune system regulator that interrupts the NLRP3 inflammasome and [...]

Le KFSHRC lance une unité mobile de traitement des accidents vasculaires cérébraux pour accélérer la prise en charge des patients

22/10/2024 - 04:11

Une première au Moyen-Orient et en Afrique du Nord RIYAD, Arabie Saoudite, 22 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) a lancé la première unité mobile de soins [...]

OnePoint Patient Care Notifies Individuals of Data Security Incident

22/10/2024 - 03:23

TEMPE, Ariz., Oct. 21, 2024 (GLOBE NEWSWIRE) -- OnePoint Patient Care (“OPPC”) announced today that it is notifying individuals whose information was involved in a recent data security incident. On August 8, 2024, OPPC [...]

Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

22/10/2024 - 02:00

Enhanced protection of vision with ANX007 treatment in healthier eyes Greater preservation of EZ in the central fovea by ANX007 in patients with less advanced GA Pivotal Phase 3 ARCHER II Data Expected Second Half 2026 [...]

The Ensign Group Schedules Third Quarter Earnings Call for Friday, October 25th, 2024

22/10/2024 - 00:02

SAN JUAN CAPISTRANO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]

GRI Bio Announces Exercise of Warrants

21/10/2024 - 23:35

LA JOLLA, CA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the [...]

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

21/10/2024 - 23:10

Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure [...]

Nova Leap Health Corp. to Present at the LD Micro Main Event

21/10/2024 - 23:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]

Vision Sensing Acquisition Corp. Announces Delisting and Subsequent Liquidation

21/10/2024 - 22:40

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ” or “ VSAC ”), a special purpose acquisition company, announced that the Sponsor, Vision Sensing [...]

Travere Therapeutics to Report Third Quarter 2024 Financial Results

21/10/2024 - 22:30

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2024 financial results on Thursday, October 31, 2024, before the open of the U.S. [...]

Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics

21/10/2024 - 22:30

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, and Genevant Sciences, a leading [...]

Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial Results

21/10/2024 - 22:25

ROCKVILLE, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Revolution Medicines Announces First Patient Dosed in Phase 3 Study Evaluating RMC-6236 in Previously Treated Patients with Metastatic Pancreatic Ductal Adenocarcinoma

21/10/2024 - 22:05

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced [...]

Pennant Announces Third Quarter 2024 Earnings Release and Call

21/10/2024 - 22:05

EAGLE, Idaho, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community

21/10/2024 - 22:05

Deadline to submit nominations is January 31, 2025 WALTHAM, Mass., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and [...]

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

21/10/2024 - 22:05

CARLSBAD, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of five abstracts at the 2024 American College of Rheumatology’s ( [...]